Malignant hyperthermia: A pharmacogenetic disorder

Rachel C. Stratman; Jeremy D. Flynn; Kevin W. Hatton

doi:10.3928/01477447-20090922-18

Malignant hyperthermia: A pharmacogenetic disorder

Rachel C. Stratman
, Jeremy D. Flynn
, Kevin W. Hatton

Producción científica: Article › revisión exhaustiva

12 Citas (Scopus)

Resumen

Given the rarity and lethality of malignant hyperthermia, it is critical that all health care providers practicing in the perioperative setting have the ability to identify and institute timely life-saving therapy for this disorder.

Idioma original	English
Páginas (desde-hasta)	835-838
Número de páginas	4
Publicación	Orthopedics
Volumen	32
N.º	11
DOI	https://doi.org/10.3928/01477447-20090922-18
Estado	Published - nov 2009

ASJC Scopus subject areas

Surgery
Orthopedics and Sports Medicine

Acceder al documento

10.3928/01477447-20090922-18

Otros archivos y enlaces

Citar esto

@article{97a7848394aa437a8a06e3c398d7ac08,

title = "Malignant hyperthermia: A pharmacogenetic disorder",

abstract = "Given the rarity and lethality of malignant hyperthermia, it is critical that all health care providers practicing in the perioperative setting have the ability to identify and institute timely life-saving therapy for this disorder.",

author = "Stratman, \{Rachel C.\} and Flynn, \{Jeremy D.\} and Hatton, \{Kevin W.\}",

year = "2009",

month = nov,

doi = "10.3928/01477447-20090922-18",

language = "English",

volume = "32",

pages = "835--838",

number = "11",

}

TY - JOUR

T1 - Malignant hyperthermia

T2 - A pharmacogenetic disorder

AU - Stratman, Rachel C.

AU - Flynn, Jeremy D.

AU - Hatton, Kevin W.

PY - 2009/11

Y1 - 2009/11

N2 - Given the rarity and lethality of malignant hyperthermia, it is critical that all health care providers practicing in the perioperative setting have the ability to identify and institute timely life-saving therapy for this disorder.

AB - Given the rarity and lethality of malignant hyperthermia, it is critical that all health care providers practicing in the perioperative setting have the ability to identify and institute timely life-saving therapy for this disorder.

UR - https://www.scopus.com/pages/publications/70450210413

UR - https://www.scopus.com/pages/publications/70450210413#tab=citedBy

U2 - 10.3928/01477447-20090922-18

DO - 10.3928/01477447-20090922-18

M3 - Article

C2 - 19902883

AN - SCOPUS:70450210413

SN - 0147-7447

VL - 32

SP - 835

EP - 838

JO - Orthopedics

JF - Orthopedics

IS - 11

ER -

Malignant hyperthermia: A pharmacogenetic disorder

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto